Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valerie Ratliff"'
Autor:
Ann G. Schwartz, Shirish Gadgeel, Kristen Purrington, Gerold Bepler, Aliccia Bollig-Fischer, Fulvio Lonardo, Angela S. Wenzlaff, Valerie Ratliff, Douglas Craig, Greg Dyson, Donovan Watza, Christine M. Lusk
Tables S1-S6 and Figures S1-S3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a88812bd8bae04e0257ca98086ac65c
https://doi.org/10.1158/1078-0432.22470897
https://doi.org/10.1158/1078-0432.22470897
Autor:
Ann G. Schwartz, Shirish Gadgeel, Kristen Purrington, Gerold Bepler, Aliccia Bollig-Fischer, Fulvio Lonardo, Angela S. Wenzlaff, Valerie Ratliff, Douglas Craig, Greg Dyson, Donovan Watza, Christine M. Lusk
Purpose:Identifying novel driver genes and mutations in African American non–small cell lung cancer (NSCLC) cases can inform targeted therapy and improve outcomes for this traditionally underrepresented population.Experimental Design:Tumor DNA, RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6394af493fd761c584dba2115f16e0
https://doi.org/10.1158/1078-0432.c.6527718.v1
https://doi.org/10.1158/1078-0432.c.6527718.v1
Autor:
Christine Neslund-Dudas, Donovan Watza, Kristen S. Purrington, Kang Chen, Valerie Ratliff, Gerold Bepler, Gregory Dyson, Angela S. Wenzlaff, Christine M. Lusk, Ann G. Schwartz
Immunotherapy is a promising advancement in the treatment of non-small-cell lung carcinoma (NSCLC), although much of how lung tumors interact with the immune system in the natural course of disease remains unknown. We investigated the impact of the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3318c86ade54b3ddea4622a1b5bca85
https://europepmc.org/articles/PMC6314333/
https://europepmc.org/articles/PMC6314333/
Autor:
Donovan Watza, Kristen S. Purrington, Ann G. Schwartz, Gerold Bepler, Shirish M. Gadgeel, Angela S. Wenzlaff, Gregory Dyson, Douglas B. Craig, Aliccia Bollig-Fischer, Fulvio Lonardo, Christine M. Lusk, Valerie Ratliff
Publikováno v:
Clin Cancer Res
Purpose: Identifying novel driver genes and mutations in African American non–small cell lung cancer (NSCLC) cases can inform targeted therapy and improve outcomes for this traditionally underrepresented population. Experimental Design: Tumor DNA,